Cell Therapy

News

Cell Mogrify gets £420k funding for regenerative cell therap...

UK cell therapy company Cell Mogrify has been awarded £420,000 funding from Innovate UK to accelerate its data-driven cell conversion programmes.

R&D

Will cell and gene therapies disrupt reimbursement?

Cell and gene therapies could prove disruptive in terms of the life-changing benefits they could bring to people with rare diseases and cancers – but they could also mean healthcare systems

News

Nearly 300 gene and cell therapies in development - report

Pharma is becoming increasingly focused on gene and cell therapies, with nearly 300 in clinical development or awaiting review by the FDA, according to a new report from US trade body PhRMA

News

Roche and SQZ expand cell therapy deal to more than $1.3bn

US biotech SQZ Biotechnologies has expanded a collaboration with Roche to develop cancer therapies based on antigen presenting cells, which may be able to target solid tumours and which are

News

Gilead signs biotech deal arming T-cells to attack solid tum...

Gilead’s Kite unit has signed a deal with the biotech HiFiBiO (High Fidelity Biology) to discover T-cell receptors that could lead to cell therapies capable of targeting solid tumours.

Partner Content